share_log

HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target

Moomoo 24/7 ·  Mar 20 06:39

HC Wainwright & Co. analyst Joseph Pantginis reiterates Tempest Therapeutics (NASDAQ:TPST) with a Buy and maintains $47 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment